Efficacy and safety of hypofractionated radiotherapy combined with temozolomide in patients with newly diagnosed glioblastoma with poor prognosis: a single-center retrospective analysis

BackgroundThe optimal management for newly diagnosed glioblastoma (GBM) patients with poor prognostic features, such as RPA class IV-VI or rapid early progression, remains debated. This study evaluated the efficacy and safety of postoperative hypofractionated radiotherapy (HFRT) with concurrent temo...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Fangmeng Fu, Li Ma, Fengming Lan, Peng Chen, Teng Zou, Ling Lei, Renba Liang, Manyi Zhu, Jianghu Zhang
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2026-05-01
Rangatū:	Frontiers in Oncology
Ngā marau:	efficacy glioblastoma hypofractionated radiotherapy poor prognosis temozolomide
Urunga tuihono:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1782296/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!